A timeline of MLB’s drug-testing rules

Aug. 30, 2002 – Players and owners announce a collective

bargaining agreement that includes a joint drug program for the

first time since October 1985. The deal calls for a survey urine

test for banned steroids in 2003 and 2004, and if more than 5

percent of tests are positive in a year, for testing with penalties

to start the following year and continue until less than 2.5

percent test positive in two consecutive years combined.

Nov. 13, 2003 – MLB says between 5 and 7 percent of 1,438

anonymous tests were positive for steroids, triggering the start of

testing with penalties in 2004. A first positive test results in

treatment and a second in a 15-day suspension without pay or fine

of up to $10,000. Penalties increase to a 25-day suspension or fine

of up to $25,000 for a third positive test, a 50-day suspension or

fine of up to $50,000 for a fourth and a one-year suspension or

fine of up to $100,000 for a fifth.

Jan. 13, 2005 – Under pressure from Congress, players and owners

announce a new drug agreement in which first offenses result in a

10-day suspension, second violations in a 30-day ban, third in a

60-day penalty and a fourth in a one-year ban. Fifth violations are

subject to discipline determined by the commissioner.

Nov. 15, 2005 – Still under pressure from Congress, players and

owners announce a new drug agreement in which first offenses result

in a 50-game suspension, second in 100-game bans and third in

lifetime suspensions. Many stimulants are banned for the 2006

season. The deal is along the lines of what Baseball Commissioner

Bud Selig had proposed on April 30.

April 22, 2008 – Following the Mitchell Report on drugs in

baseball, players and owners adopt George Mitchell’s

recommendations that the drug program’s Independent Program

Administrator be appointed for a multiyear term, be removed only in

narrow circumstances and issue annual public reports. Random urine

testing is increased.

Nov. 22, 2011 – Players and owners agree to blood testing for

human growth hormone during spring training in 2012.

June 7, 2012 – Players and owners agree to add HGH blood testing

during spring training, during the offseason and for reasonable

cause. Random urine testing is increased, players suspended before

the All-Star game become ineligible for election or selection to

the game and collection rules are modified following the successful

grievance that overturned the suspension of Milwaukee’s Ryan

Braun.

Jan. 10, 2013 – Players and owners agree to HGH blood testing

throughout the regular season and to have the World Anti-Doping

Agency laboratory in Laval, Quebec, keep records of each player,

including his baseline ratio of testosterone to epitestosterone.

The lab will conduct Carbon Isotope Ratio Mass Spectrometry (IRMS)

tests of any urine specimens that ”vary materially.”